Compare SONO & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SONO | PLSE |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2018 | 2015 |
| Metric | SONO | PLSE |
|---|---|---|
| Price | $12.80 | $21.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $19.67 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.2M | 228.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $1,443,276,000.00 | N/A |
| Revenue This Year | $5.04 | $840.00 |
| Revenue Next Year | $6.53 | $287.54 |
| P/E Ratio | $17.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.63 | $12.56 |
| 52 Week High | $19.82 | $26.30 |
| Indicator | SONO | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 33.11 | 55.16 |
| Support Level | $12.64 | $13.75 |
| Resistance Level | $13.94 | $23.18 |
| Average True Range (ATR) | 0.51 | 1.40 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 0.00 | 68.49 |
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.